fda removes semaglutide from drug shortage list february 21 2025 As of 21, 2025, the updated its list FDA says shortage of Ozempic

The microdosing trend with GLP-1 medications reveals something we see constantly in women's health: patients innovating faster than the research can keep up

In response to different extracellular stimuli, the complex may dissociate and JNK can phosphorylate c-Jun, a component of the activator protein-1 transcription factor

The FDA had logged more than 455 adverse event reports tied to compounded semaglutide and more than 320 tied to compounded tirzepatide as of early 2025

Nausea usually resolves by day 4-5 as your body adapts

Exosome-derived CDC42 from hypoxia-pretreated neural stem cells inhibits acsl4-related ferroptosis to alleviate vascular injury in Parkinsons disease mice models